Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-15-004745)

Filing Details

Accession Number:: 0000899243-15-004745
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-14 16:31:09
Reporting Period:: 2014-08-14

Filing Date:: 2015-09-14
Accepted Time:: 2015-09-14 16:31:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1042418	Hedgepath Pharmaceuticals Inc.	HPPI	Services-Commercial Physical & Biological Research (8731)	541641133

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584617	Hedgepath, Llc	324 S. Hyde Park Avenue, Suite 350 Tampa FL 33606		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.0001 Par Value Per Share	Disposition	2015-09-10	20,000,000	$0.00	84,687,069	No	4	S	Direct
Common Stock, $.0001 Par Value Per Share	Acquisiton	2014-08-14	82,156,842	$0.00	104,687,069	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	C	Direct

Footnotes

On September 10, 2015, the Reporting Person transferred 20,000,000 shares of common stock in a private transaction to a third party in satisfaction of $1,577,797.54 in then outstanding debt.
On August 14, 2014, the Reporting Person converted 241,636.720 shares of its Series A Preferred Convertible Stock into 82,156,842 shares of common stock.